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Abstract  
Background Little is known about the burden of TB and associated factors among 
pregnant women in resource poor settings.  
Objective: To assess the prevalence of smear positive tuberculosis and associated 
factors among pregnant women attending antenatal care service. 
Method: This study employed institution based cross-sectional study in Northwest 
Ethiopia. All pregnant women in North Gondar Zone were used as a source population. 
Sample was estimated using Open-Epi soft ware and all hospitals in North Gondar Zone 
were included in the study. Data were collected by using interview administered 
questionnaire and three sputum (spot-morning-spot) samples were collected from those 
pregnant women who had cough. Sputum smear was done by using Light Emitted 
Diode Florescent Microscope.  
Data were entered using Epinfo version 3.5 statistical software. The statistical Package 
for the Social science/SPSS Version 20.0 was also employed for descriptive and logistic 
regression analysis.  
Result: A total of 1272 pregnant women were screened for TB. The prevalence of 
smear-positive TB was 864/100,000 pregnant women (95% CI: 402-1122). Higher rates 
of smear-positivity were observed among HIV positive [AOR= 7.24; 95% CI: (2.01-
26.03)], rural residents [AOR=5.55; 95% CI: (1.398-22.068)] and family history of TB 
[AOR=55.78; 95% CI: (12.373-251.536)]  
Conclusion  
This study revealed higher rates of smear-positive TB. Being HIV positive, rural 
residence, and family history of tuberculosis were identified as possible associated risk 
factors of smear-positive tuberculosis. Strengthening the existing health education 
about transmission, screening of pregnant women who had cough for two weeks or 
more, and strengthening collaboration of TB and HIV with antenatal care clinics were 
recommended. 
Keywords: cross-sectional, LED Fluorescent microscope pregnant women, Risk factor, 
  Smear-positive, 
  viii
    1. Introduction  
1.1 Background and Statement of the problem 
Even at the moment after the accessibility of successful anti TB drugs for more than half 
a century, TB remains a major cause of global morbidity and mortality. One-third of 
world’s population is estimated to be infected with MTB [1, 2]. There were about 8.6 
million new TB cases (together with 4.1 million new smear-positive cases) and 410,000 
women pass away per annum, in which it disproportionally affects women of the 
reproductive age groups(15-44) year [2].  
Geographically, the load of TB is highest in developing countries. India and China 
shared almost 40% of the world’s TB cases; the South-East Asia and Western Pacific 
region account for 60%. The African Region has around one quarter of the world’s 
cases, and the maximum rates of cases and deaths comparative to population [1, 
2].The prevalence of active TB in pregnant and postpartum women from high burden 
countries like India which accounts to be (19%-34%).  Kenya, South Africa and Rwanda 
(>60 TB cases per 100 000 population annually) and low-burden tuberculosis countries, 
UK, USA (<20 cases per 100 000 population per year or <10 cases of total population) 
were reported. Rates of active tuberculosis ranges from 0.7% to 7.9% among HIV-
positive women in high-burden countries, and is as high as 11% if they are positive for 
tuberculin skin test (TST) [2, 3]. High-burden countries may miscalculate prevalence 
because many women do not have contact to healthcare when pregnant[2].Few 
countrywide programs gather or account pregnancy-related  tuberculosis data to the 
World Health Organization (WHO). 
Data from sub-Saharan Africa, show the consequence of Mycobacterium tuberculosis 
infection as a main cause of maternal mortality, especially in the context of HIV co 
infectivity[4, 5]. Mycobacterium tuberculosis/HIV co-infection is frequent, in areas of high 
TB incidence and prevalence. In a review of maternal mortality in Johannesburg, South 
Africa, 70% of death in women were HIV-related, rather than death from obstetric 
causes, and mainly from TB and pneumonia[5].  
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Ethiopia is categorized among the 22 High Burden Countries (HBCs) and rank seventh 
[2] and TB account for the major percentage of hospital admission and reported as 
being the third principal cause of hospital deaths second  to malaria and obstetric cases 
[6]. In the year 2012, Ethiopia TB and Leprosy control, the nationwide approximate  
prevalence, incidence and mortality rates of TB were 294, 261 and 35 per 100,000 
population respectively, whereas smear-positive PTB (SPPTB) cases were estimated to 
be 46,634 amongst adults aged above 15 years [6]. And a study in North west Ethiopia 
in 2011, prevalence of sputum smear positive tuberculosis were 178/100,000 
population, age greater or equal to 14, [7] and there were high rates of smear positive 
tuberculosis among females and prevalence of smear positive case detection rate 
through active case finding were 3.3 times higher for females than male[7]. Different 
population based researches in Ethiopia under smear positive tuberculosis found that 
females are found to be more prevalent than male[7, 8]  
These facts remain about pregnancy and tuberculosis, the exact prevalence of 
tuberculosis in pregnancy does not readily exist in many countries due to a lot of 
confounding factors. Amongst African women in the early reproductive years case 
finding rate of sputum smear positive tuberculosis  is 1.6-2.4 times higher than in 
women age 44 and older and other population segments [9]. Mean while Antenatal care 
is a vital spot of contact of pregnant women, to assess and access regular screening for 
TB in pregnant women, it is not ordinary practice in many settings which leads 
hindrance in diagnosis, maternal and child mortality and there is no clear research done 
on the prevalence of smear positive tuberculosis and factors which contribute to the 
burden of tuberculosis in pregnant women in the study area or even in Ethiopia. So   
that, this study primarily focuses on the prevalence of smear-positive tuberculosis and 
associated factors among pregnant women attending ANC service, in North Gondar 
Zone, northwest Ethiopia. 
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1.2 Literature review   
Tuberculosis is a communicable disease caused by the bacillus Mycobacterium 
tuberculosis. It characteristically affects the lungs (pulmonary TB) but can affect other 
sites as well (extra pulmonary TB). The disease is spread in the air when peoples who 
are sick with pulmonary TB expel bacteria, for example by coughing. In general, a 
relatively small proportion of people infected with Mycobacterium tuberculosis will 
develop TB disease; however, the chance of developing TB is much higher among 
people infected with the human immunodeficiency virus (HIV) and women in 
underprivileged surroundings of reproductive age and without treatment mortality rates 
are high[1]. 
1.2.1 Magnitude of tuberculosis in pregnant women  
An intensified case finding study in South Arica, by sputum sampling for pulmonary 
tuberculosis confirm the prevalence of tuberculosis among pregnant women was high 
which is(3.3%) [3]. In addition another study in Tanzania, Dar Es Salam in 2009, sputum 
microscopy/smear positive tuberculosis among women attending MCH and family 
planning was 3.8%[9]. Of 5731 pregnant women attending ANC in Nsanje district, 
Malawi, 22 were registered smear positive PTB, giving an annual case notification rate 
of 384 per 100,000 pregnant women and the study conclude that smear positive 
pulmonary tuberculosis case notification rate was over twice as high as in pregnant 
compared to non pregnant women[10].  
Ethiopia carries the highest burden of TB in the Horn of Africa [1] and it stands 7th 
among the 22 high-burden countries in the world[11]. The national TB notification rate 
(prevalence and incidence) of tuberculosis cases was 250 and 290 per 100,000 
populations respectively a report of WHO 2012, and over all smear positive tuberculosis 
become 284 per 100,000 population[1]. In 2013 a community based cross sectional 
study in Dabat district, North West Ethiopia shows the prevalence of smear positive 
tuberculosis among adults age ≥14 was 174 per 100,000 which was greater more than 
half from a study in southern part of Ethiopia, which was 78 per 100,000 population and 
from here there were high rates of smear positive tuberculosis which is females are 3.2 
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times more likely to be AFB positive than males, that is in the study area Dabat District 
out 41 positive for AFB 32 were women. And they conclude that two third of smear 
positive tuberculosis cases in the community were undiagnosed in the study area[7, 12].  
1.2.2 Risk Factors contributing to tuberculosis during pregnancy  
There are different risk factors associated with tuberculosis infection, especially during 
pregnancy.  
Socio demographic factor 
The risk of acquiring TB infection increases with age from early life to early adult life, 
probably, because of increasing number and rate of frequency of contacts[13]. TB is 
mainly a disease of adults in the age group of 15 - 49 years.  
In most settings, TB incidence rates are higher for males at all ages except in childhood, 
when they are higher in females. Studies have reported that sex differentials in 
prevalence rates begin to emerge between 10 and 16 years of age, and stay higher for 
males than females afterward[14]. TB is the 3rd leading cause of death worldwide 
among women aged between 15 and 44 years and it is the 4th leading cause of death 
among women aged 10-19 years in low income countries. Once infected, women of 
reproductive age are more susceptible to developing TB than men of the same age.  
Although the impact of gender dynamics on TB detection and treatment has not been 
studied comprehensively, but there are some clear associations. Gender-related 
barriers can impact women’s access to TB information and services, which contribute to 
late or missed case detection in women. Where women do not control family property, 
they often delay in looking for medical care. On the other hand, women are not 
permitted to leave the home without permission, and are afraid of being seen going to a 
TB clinic, and they often miss health promotion programs and remain unaware of TB 
symptoms. Where women suffer stigma and discrimination related to their HIV or TB 
status, they may not seek treatment for fear of rejection. Some studies have shown that 
women wait up to twice as long as men to seek treatment for TB, which can increase 
the severity of their sickness, decrease the success of treatment, and raise the risks 
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that they will infect others. Different data’s suggest, however, that once in treatment, 
women in many settings are more likely than male counterpart to complete treatment 
[11, 14]. 
Socio Economic and Environmental Factor  
Tuberculosis has been associated with factors linked to socioeconomic scarcity: uch as 
poverty, overcrowding and malnutrition, were commonly faced by women in resource 
limited countries. Of the 22 countries that are home to 80 percent of the world’s people 
with active TB, 17 have an annual Gross Domestic Product (GDP) of less than US 
$760[15]. since women account for about 70 percent of the world’s poor, in developing 
countries they are disproportionately affected by the disease[15, 16]. This poses a 
significant challenge to TB control, as poor women are less likely to seek medical care.  
The association between TB and poverty was shown by the decline in TB burden with 
the better living situation in developed countries prior to the introduction of treatment. 
Improved living condition was also found to reduce the risk of infection from 4- 6 % per 
annum. On the contrary, certain aspects of poverty make women more vulnerable to 
develop active TB. Cramped living conditions, overcrowding, and poor ventilation ease 
the spread of TB bacteria. In addition, women living in poverty are at an increased risk 
of becoming commercial sex workers. Millions of women and girls are forced into 
commercial sex work each year; over one million girls are from India alone. Women and 
girls who engage in sex work are at an increased risk of contracting TB from clients. 
This risk is exacerbated by their confined living conditions and susceptibility to HIV[17-
19]. Crowding increases the risk of exposure by  increasing the likelihood of contact 
between susceptible persons and infectious tuberculosis cases as well as the intimacy 
of exposure.  
Women’s social roles place them at a higher risk of contracting TB. Indoor food 
preparation is particularly connecting to TB. In developing countries, women often cook 
indoors in very confined spaces using biomass fuel such as wood or animal dung. 
Studies showed that women who cook with biomass fuel are more likely to develop 
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active TB[16, 20]. It is believed that smocks from fuels can weaken women’s respiratory 
systems and impair the immune system’s ability to fight off bacteria [1]. 
Residence also play a vital role of an important factor for tuberculosis infection and 
development that is more TB patients were reported from urban than rural areas 
because of overcrowding, poverty and HIV infection [20]  
Clinical diseases  
The incidence of TB was reported greatest among people with impaired immunity, HIV 
infection, or diabetes[21].  A multifaceted interaction exists between TB and HIV 
infection. HIV increases the risk of infection, as it reactivates LTBI and increases the 
progression to active disease. A number of studies have confirmed the contribution of 
HIV in maternal mortality and morbidity[22, 23]. Prevalence of TB in HIV-infected 
pregnant women in South Africa is similar to that of the general population: 
approximately 795/100 000[24]. In 2009, the prevalence of active TB in HIV infected 
women attending antenatal care in Soweto, was found to be 688/100 000; higher than 
the prevalence in HIV-uninfected women (201/100 000). Similar study in Nigeria HIV 
infection and TB during pregnancy is a particularly lethal combination which is in 
dependent risk factors for maternal mortality[25]. In a study of maternal mortality in 
South Africa, there was a 3.2-fold increase in the relative risk of death in mothers with 
TB-HIV co-infection, compared with HIV-uninfected mothers with TB infection, and 54% 
of maternal deaths caused by TB were attributable to co-infection with HIV[4, 23]. In 
Zambia, TB accounts for 25% of all non obstetric maternal deaths, most of these among 
women with TB-HIV co-infection[22]. There are also some studies in Ethiopia that HIV 
infected pregnant women have high prevalence of tuberculosis than non HIV pregnant 
women. An institution based cross sectional study on the prevalence of smear positive 
tuberculosis among diabetic’s patients in Dessie referral hospital North east Ethiopia 
shows 6.2% pulmonary tuberculosis which is higher when compared to the general 
population in the study area[21]. 
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Behavioral factor  
Furthermore the social and demographic factors, lack of education, smoking habit, drug 
addiction etc. contribute to the incidence and transmission of TB among pregnant 
women[26].   
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Figure 1: Conceptual framework on prevalence of smears positive TB and 
associated factors among pregnant women attending ANC in North Gondar Zone 
Hospitals, Northwest Ethiopia, 2014 (Source: WHO and diferrent Litratures) 
 
 
 
 
7 
 
1.3 Justification 
Finding tuberculosis in the most vulnerable groups, women in reproductive age are an 
urgent priority. Reduction of tuberculosis transmission, morbidity and mortality relays 
largely on intensified case finding and sputum screening with consequence early 
initiation of adequate treatment[3]. This is particularly important among pregnant women 
in resource limited settings where tuberculosis is a cause of non obstetrical or indirect 
maternal death [1,2]. And control tuberculosis transmission from mother to child and 
death due to TB. This is the key strategy towards meeting MDG (halt the spread and TB 
incidence by 2015) and contributes the reduction in child and maternal mortality goal 4 
and 5. So that this study will helps to measure the burden of tuberculosis among 
pregnant women in the study area and factors which may contribute to TB during 
pregnancy, and will provide base line information to link tuberculosis screening at ANC 
service in which large number of women could be opportunistically screened for TB, 
which make active case finding cost effective and sustainable.  
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2. Objectives 
2.1 General objective 
To determine the prevalence of smear-Positive tuberculosis and associated factors 
among pregnant women attending ANC in North Gondar Zone Hospitals,  North west 
Ethiopia. 
2.2 Specific objectives  
1. To measure the prevalence of smear positive tuberculosis.  
2. To identify factors associated with tuberculosis.  
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3. Methods 
3.1 Study design and period 
Institution based cross sectional study was used to estimate the prevalence of smear 
positive tuberculosis and associated factors among pregnant women from March to May 
2014.  
3.2 Study area 
The study was conducted in hospitals of North Gondar Zone. North Gondar    is found at 
an altitude of 2100 to 2870 meters above sea level to the North West of the Country and 
is 748 km far from the capital, Addis Ababa.[27] 
North Gondar zone is the largest zone in Amhara region and it is divided into 24 
woredas of which there are four city administration woredas and 576 kebeles. North 
Gondar Zone had a total population of 3,286,351, which live in 44,868.44sq.km [27]and 
there are 3 hospitals, 132 health centers and 566 health posts by this the total health 
service coverage is 97% and ANC service coverage of 95.8% [27]. 
3.3 Source population  
All pregnant women in North Gondar Zone were taken as the source population.  
3.4 Study population 
The study population was pregnant women who attended antenatal care during the 
study period in selected Hospitals. 
3.5 Inclusion criteria  
All pregnant women ≥18 year of age presenting to the hospitals for ANC service   were 
eligible to participate. 
10 
 
   3.6 Exclusion criteria 
Women who were unable to provide verbal consent, critically ill with other obstetrics 
case were excluded.  
    3.7 Sample size determination 
Sample size was determined by using OpenEpi version 2.3, soft ware with the following 
assumptions 
- taking the total pregnant women attending ANC 13450  
- prevalence of tuberculosis3.8% [28] 
- 95% confidence level and  
- 1% of margin of error  
With this assumption the final sample size was1272.  
 
3.8 Sampling procedure and technique 
All Hospitals in the study area are taken by doing so, each hospital ANC service 
2013/2014 plan (13450) taken as a source population and pregnant women flow was 
estimated by each hospital was 41, 23 and 18 for UoG referral hospital, Debark 
hospital, and Metema hospital respectively each day.  We use systematic random 
sampling technique, in which every 2nd member study units that was available at the 
time of data collection and who express their willingness were included in the sample. 
From a total of 2546 antenatal care attendants, 1272 study subjects from the three 
hospitals were included in the study. 
Distribution of the estimated sample size to each hospital was done by using a simple 
population proportion formula as follows:- 
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North Gondar Zone Hospitals (3), 
purposively included
Debark 
Hospital 
 
2890 PW 
UoG 
Hospital 
7975 PW 
Metema 
Hospital 
2585 PW
Simple Population proportion 
754 
Total 
1272
244 274 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic presentation of sampling procedures on prevalence of Smear 
positive TB and associated factors among pregnant women Northwest Ethiopia, 
2014.  
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3.9 Variables  
Dependant variable 
? Prevalence of Tuberculosis  
Independent variable 
? Socio demographic characteristics:  
- Age, marital status, educational status, religion, occupation   
? Socio economic and environmental factor 
-  Residence 
- Family history of TB 
- Biomass fuel use 
- Crowding, poor ventilation 
- Family size 
? Behavioral factor 
- alcohol consumption,   
- smocking  
? Clinical diseases  
             - HIV 
- Diabetics  
               - Malnutrition  
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3.10 Operational definition 
Women at ANC: pregnant women who visit antenatal care clinic at list once during the 
study period.   
Smear positive tuberculosis/PTB: When subjects with two sputum smear-positive 
results for AFB/LED Fluorescent microscope or one positive smear result for AFB/LED 
in the case of HIV positive subjects.  
TB suspects: is any person with symptoms and signs suggestive of TB in particular 
cough of two weeks or more duration. 
3.11 Design and Data collection procedure  
Institution based cross sectional study was conducted to estimate the prevalence of 
smear-positive tuberculosis and to find out factors associated with prevalence of TB 
among women s’ attending their antenatal care in all hospitals of North Gondar Zone. 
Those Hospitals were taken considering different climate and way of living conditions. 
Systemic random sampling technique were employed to select Pregnant women who 
came to attend their ANC service to each health institution for interview and then 
women who had cough for at least two weeks and able to produce sputum were 
selected/send for further laboratory smear identification. 
A total of 15 health professionals (6 nurses in ANC clinic, 6 laboratory technologists and 
3 supervisors) were recruited and trained for data collection on screening of pulmonary 
tuberculosis by asking persistence cough and cardinal symptom, inclusion criteria, 
sputum collection, how to treat pregnant women and produce sputum and record 
keeping. Each data collector handled all pregnant women coming to attend their ANC in 
the given hospital during data collection period   interviewed every 2nd pregnant women 
using a pretested and structured symptom screening questioner. After obtaining written 
informed consent, demographic, socio-economic and other illness history (cough for 
more than two weeks, shortness of breath, night sweet, and chest pain e.t.c) were 
collected for each study subjects. ANC nurses link those pregnant women who had 
cough of at list two weeks to the laboratory technologists and the laboratory 
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technologists were collect three sputum samples,(spot morning spot) for each TB 
suspected pregnant women using a labeled sputum container. The first sputum sample 
was collected during the interview day and the second early in the following day by 
consulting them to produce and collect sputum before they eat or drink and the third 
sample was collected while they bring the morning sample. Data collectors traced 
actively suspected individuals who did not provide samples. Reason for not providing 
the sample   were recorded on the questionnaire (not able to produce, not willing to 
produce sputum, not present and others).  
Sputum smear microscopy  
Sputum-smear microscopy using a light emitted diode (LED) fluorescence microscopy 
was done in both hospitals on the day of collection following the manufacturer’s 
procedures (PARTEC GmbH) [31]. Three slides were stained for every individual and 
the slides were read by two experienced laboratory technologists separately.  
Data quality control 
Training was given to the data collector, nurses and laboratory technologists and 
supervisors on the objective, relevance of the study, informed consent and techniques 
of interview, inclusion exclusion criteria, sampling technique e.t.c. Before going to data 
collection, The English version questionnaire was translated in to Amharic and then 
back to English to maintain its consistency, a pre-test was conducted on 5% pregnant 
women at ANC in other Gondar health center to ensure the validity of the questionnaire. 
The collected data was checked for completeness and consistency by the supervisors, 
on daily basis by the principal investigator. Appropriate correction was made to the data 
collectors for any error or ambiguity and incompleteness in the following days before 
preceding the next day activities. Efforts were made to ensure a high quality of sputum 
by appropriate orientation of participants on how to produce sputum from lung and to 
produce at least 3 ml of sputum and supervision will be made by laboratory workers. 
Poor specimens were replaced with an immediate spot collection. The sputum sample 
was prepared on slide immediately as soon as possible for each participant at the day 
of collection and samples were preserved for discordant results and for further 
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confirmation. The slides were read by two experienced laboratory technologists 
separately. All laboratory investigators followed accepted standard operating 
procedures (SOPs). For discordant results, a third expert senior laboratory technologist 
prepares and read the slides the third reader report was taken as final. Repeated 
examinations were done for pregnant women with one positive smear and one negative 
smear. All positive samples and 10% of negative samples were re-examined by senior 
laboratory technologists at the University of Gondar Teaching Hospital Laboratory. All 
smear-positive cases identified during the study period were treated according to the 
national guidelines.   
4. Data management and analysis 
Data entry and cleaning carried out using the Epi Info version 3.5 statistical software, 
were analyzed on SPSS software package version 20.0 (SPSS, Inc., Chicago, IL, USA). 
Descriptive statistics, such as frequency distribution, mean percentage and standard 
deviation were employed for most variables. Tables and graphs were also used for data 
presentation. Binary logistic regression was used to identify factors associated with 
smear-positive tuberculosis. Multiple logistic regression Model was fitted to control the 
possible effect of confounders and finally the variables which had independent 
association with TB were identified on the basis of OR, with 95%CI and p-value less 
than 0.05. The variables were entered to the multivariate model using the forward 
stepwise (Likelihood ratio) regression model.  Model fitness was checked using Hosmer 
and Lemeshow goodness of a fit test (0.894). 
5. Ethical Consideration 
The study protocol was reviewed and approved by Institutional Review Board of the 
University through Institute of Public Health of Collage of Medicine and Health Science. 
Hospital managers (administrative) of the hospitals in the study areas were consulted 
and permission obtained prior to data collection. Written informed consent was obtained 
from each study subjects. The purpose and benefits of the study was explained to the 
respondents. Confidentiality of the information was maintained throughout by excluding 
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names as identification in the questionnaire and keeping their privacy during the 
interview by interviewing them alone.   
6. Dissemination of findings 
The results of the study will be submitted to district hospitals, University of Gondar 
Research and Community Service Process Office, Regional health Bureau and Federal 
Ministry of Health.  The results will be disseminated to Ethiopian Public Health 
Association and other interested governmental and Non-governmental organizations. 
This paper will be published in peer-reviewed scientific journal. Public outreach activities 
for realizing research findings, for example through conference, will also be important 
avenue for dissemination 
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7. Results 
There were a total of 1272 pregnant women aged ≥18 years screened for tuberculosis 
through a symptom interview questioner. The mean standardization age of respondents 
was 27.5 (±SD 5.2) years ranging from 18-43 years. About 37.4% of respondents had 
no formal schooling. As to residence, about 930(73.1) and 342(26.9) live in urban and 
rural respectively. 
Table 1: Socio Demographic Characteristics of Pregnant Women in Northwest 
Ethiopia, 2014 (n=1272) 
Variables Number 
 
Percent 
 
Age                            
18-25  
 26-35 
   >36 
 
478 
682 
112 
 
  37.6 
  53.6 
   8.8 
 
Educational level        
   No formal education 
   Primary education 
   Secondary education 
   Tertiary education  
 
476 
216 
303 
277 
    
   37.4 
   17.0 
   23.8 
   21.8 
Marital status             
   Single  
   Married 
   Divorced  
   Widowed  
 
52 
1184 
31 
5 
    
   4.1 
   93.1 
   2.4 
   0.4 
Occupation                
   House wife 
   Privet work 
   Government Employee 
Residence  
  Urban  
  Rural  
 
705 
326 
241 
 
930 
342 
   
   55.4 
   25.7 
   18.9 
 
   73.1 
   26.9 
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Duration of cough 
Majority of smear-positive pregnant women reported a cough of more than two weeks, 
which indicates delay in diagnosis.  
 
Figure 3: cough duration and smear positivity of pregnant women North Gondar 
Zone hospitals, 2014 
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Symptom screening 
Screening of tuberculosis during pregnancy using cardinal signs  is often difficult 
because of non specific symptoms of pregnancy which may overlap with tuberculosis. 
 
Figure 4: Screening smear positive TB among pregnant women using cardinal 
signs in North Gondar Zone, Northwest Ethiopia, 2014  
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7.1 Prevalence of smear positive Tuberculosis 
From 207 individuals who reported cough, 11 (5.3%) were smear- positive. Thus, the 
prevalence of smear- positive TB was 864per100,000 in persons ≥18 years (95% CI: 
401-1122).  
7.2 Factors associated with smear positive tuberculosis 
Higher rates of smear positivity were observed among HIV positive [AOR: 7.24; 95% CI 
(2.01-26.03)], and rural residence [AOR: 5.5; 95% CI: (1.398-22.068)] (Table 2). 
In the Bivariate analysis, family size, diabetics, residence, HIV infection, previous 
exposure and family contact of tuberculosis were associated with smear-positive 
tuberculosis in pregnant women 
However rural residence, HIV infection family history of tuberculosis was significantly 
associated with smear-positive tuberculosis after the multivariate logistic regression 
analysis after controlling effect of confounding.  
Higher rates of smear-positivity were observed among pregnant women with family 
history of TB [AOR: 55.78; 95% CI: (12.373 -251.536)].  
Furthermore respondents from rural area were 5.5 times more likely to have smear-
positive TB than women from urban residence [AOR: 5.5, 95% CI: (1.398-22.068)].  
The study also showed statistically significant association between smear-positive 
tuberculosis and HIV infected pregnant women. Women who were HIV positive were 
7.24 times more likely to have smear-positive tuberculosis as compared to those HIV 
uninfected one [AOR: 7.24, 95% CI (2.01-26.03)].  
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Table 2: prevalence of smear-positive TB detected by selected socio-
demographic Environmental and Clinical factors of pregnant women in North 
Gondar Zone Hospitals, Northwest Ethiopia, 2014 (n=1272) 
Variables  Positive for     
FM 
Yes         No  
Crud OR (95%) CI       Adjusted OR (95%)  
Family size   
8            325 
3            936 
 
7.68(2.025-29.122)    
1 
                                          
          ≥5 
          1-4 
*statically significant variable for tuberculosis which P-value < 0.05 
 
Diabetics  
          Positive 
          Negative  
 
1            11 
10          1250 
 
11.364(1.338-96.54)
 
 
 
1 
   
             5.55(1.398-22.068)* 
 Residence  
         Rural 
         Urban  
6            336 
5            925 
3.304(1.002-10.896)
 1 
  
 Family history TB
         Yes               
          No                
 
 5             19 
 6            1242 
 
54.474(15.29-194.04) 
1    
 
               55.78(12.37-251.53)* 
     HIV 
              7.24(2.01-26.03)*           Positive 4            108 6.101(1.758-21.170)
          Negative  7            1153 1 
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8. Discussion  
This finding revealed that prevalence of smear positive tuberculosis among pregnant 
women was 864 per 100,000 populations.  
The measured prevalence is almost equivalent to an active tuberculosis case finding 
among pregnant women presenting to ANC in Soweto, South Africa which is 889per 
100,000 populations[23], this may be due to the higher prevalence of HIV in these two 
settings.  
However the result was smaller than a study in Tanzania, Dar Es Salaam 3.8% and 
South Africa 3.3% [9, 28] which may be due to the study area, Dar Es Salaam has a 
high tuberculosis burden in the region and they enroll only women with cough attending 
in the clinic and South Africa  majority of pregnant women were HIV positive and the 
method that they used to diagnose, smear preparation plus culture was employed in the 
study.  
While lower prevalence were reported from pregnant women in Malawi[10] which was 
384 per 100,000 populations this may be due to study design they were used,  
(prospective) and using only one district hospital which may not represent all pregnant 
women and may be a good TB control strategy and low tuberculosis in the general 
population, that is Malawi is not found among the 22 high burden country (2). 
Different reports indicating that women in developing countries develop tuberculosis 
during their reproductive (15-44) age[11] and antenatal care is a good opportunity to 
access pregnant women. Even if there was no study in Ethiopia which indicates 
prevalence of TB among pregnant women this study shows relatively high prevalence. 
This may be due to including pregnant women on DOTs which revealed smear positivity 
during the study period. The current  study also trying to address pregnant women from 
different climatic, socio-economic and environmental conditions that contribute for 
tuberculosis progression in pregnant women Metema woreda which is highly HIV 
prevalent in the region, Debark woreda practicing substantial farming in which pregnant 
women may be exposed for poor nutritional status. And the overall prevalence of HIV in 
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pregnant women was 8.6% which mimics the progression and reactivation of TB in 
pregnant women.  Plus the method we were used, LED Fluorescent Microscope which 
had high sensitivity than AFB and ANC nurses and laboratory technologists are well 
experienced to screen those pregnant women and made their effort for diagnosis. 
This high prevalence of TB in pregnant women could pose problems to TB control in the 
children, their family and in the general population as tuberculosis can transmit vertically 
and horizontally to their babies and children, their family respectively.   
This study showed that family history of TB has a significant association with 
tuberculosis positivity during pregnancy. Family history of tuberculosis especially in rural 
areas is more likely to develop active tuberculosis. This finding is in line with the Guide 
Line for TB/HIV and Leprosy, the individual lives in close contact with smear positive 
pulmonary tuberculosis are more likely to develop TB [29].  
A study done in Northwest Ethiopia, Tanzania and Kenya [21,28,30], reported high 
association between pulmonary TB with family history and contact with other 
tuberculosis infected persons. This may be due to women who had contact with their 
families or other infected persons may develop active tuberculosis while they become 
pregnant. 
HIV increases susceptibility to infection with M. tuberculosis, the risk of progression to 
TB disease, and the incidence and prevalence of TB [31]. The life time risk of HIV 
positive individuals to develop TB is 20-37 times greater than HIV negative individuals. 
It also increases the likelihood of re-infections and relapses of TB [29]. In a population 
where TB/HIV is common, health services struggle to cope with the large and rising 
number of TB. HIV/AIDS has a number of impacts on TB patients and the control 
programs [31]. 
In this cross sectional study, women with HIV Sero positive were 7.24 times higher 
probability of smear-positivity than HIV uninfected pregnant women [AOR= 7.24; 95% 
CI: (2.01-26.03)].  This finding is in agreement with studies in Malawi, South Africa and 
Tanzania [10,28,32]  respectively explained that HIV Sero positive pregnant women had 
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higher prevalence of smear-positive tuberculosis infection as compared to HIV 
uninfected pregnant women. The association in this study might be due to possible 
reasons, HIV induced immune suppression and HIV increases risk of re activation of 
latent tuberculosis. On the other hand a study in Kenya [30] states that smear positive 
tuberculosis were not associated with HIV infection, this may be due to participants in 
the study were with high level of immune suppression or very low CD4 count which may 
yielding a negative smear microscopy.  
This study was also had a discrepancy in the rural to urban distribution of PTB. The 
associations between smear-positive PTB among pregnant women who lives in the 
rural areas are more prevalent. Pregnant women from rural areas are greater than five 
times more likely to be infected with tuberculosis than women from urban [AOR= 5.55; 
95% CI: (1.398-22.068)], in line with this a study two studies in Northwest Ethiopia and 
a study in Rajesh city of Bangladesh [7, 33, 34] report this association. This may be due 
to poor housing condition, family size living in one room/cell, poor socio economic 
status, poor income/nutritional status and may be lack of knowledge about transmission, 
tuberculosis screening behavior and others, in which most of cases that we found in 
rural areas are associated with family contact history of tuberculosis and others.  
Age have been associated factor in other studies [7, 21] were increase in age 
significantly associated  with tuberculosis which may be due to the risk of TB acquisition 
progression and reactivation increases as age increases. But in this study age is not 
found to be associated with smear positive tuberculosis in pregnant women. This may 
be due to study subjects found to be almost in the same range that is the mean age 
27.5 with (±SD 5.2) younger than the mean age of the above community based studies. 
.  
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9. Limitation of the study 
A gold standard for tuberculosis diagnosis (culture) was not employed, and we were not 
collected data on antiretroviral use among HIV positive pregnant women. 
Comparison with other study findings was done under some limitation, and even though 
there were a try to capture adequate sample size still it was insufficient resulting in wide 
confidence interval (CI). However we are trying to incorporate all pregnant women who 
had cough for at least two weeks during the study period and capture sputum sample, 
and laboratory tests were done by experienced persons and those who train to use LED 
microscope. 
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10. Conclusion  
The prevalence of smear positive tuberculosis was high among pregnant women.  
Being in rural residence, HIV infection, and having a family history of tuberculosis were 
factors associated with TB in pregnant women.  
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11. Recommendation  
1. Programmatic 
? Ministry of Health in collaboration with TB program should promote/ focus on 
tuberculosis screening in pregnant women, especially HIV positive pregnant 
women, 
? Regional Health Bureau and National tuberculosis control programs are 
urgently required to develop locally appropriate interventions for early 
diagnosis of tuberculosis in pregnant women  
? Should develop a screening program for every ANC service providers of 
health institutions  
? Should strength sustainable health education using locally appropriate 
materials and screening program for pregnant women during their follow up  
? Strengthening collaboration of TB/HIV department and ANC clinics. Referral 
hospitals like University of Gondar Hospital by now doing Gene Expert, which 
is more sensitive than other methods for HIV patients and children under five, 
considering the burden the program should include pregnant women who had 
cough at list two week and suspected one. 
2. For health care providers 
? They should conduct TB screening in ANC clinics effectively other than 
cardinal signs  
3. For researchers 
? Further research and investigation is needed to understand burden of TB in 
women of reproductive age by developing different methods for pregnant 
women other than cardinal signs. 
4. To pregnant women 
? Should screen for tuberculosis as soon as possible when they fell cough of 
more than two weeks and other cardinal signs. 
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13. Annexes  
Questionnaire for the  assessment of Prevalence of Smear positive Tuberculosis 
and associated factors in Pregnant   Women attending ANC in North Gondar Zone 
Hospitals. 
Consent Statement 
Nice to meet you. My name is ________________________and I am a data collector 
for the research to be conducted by a team of researcher from university of Gondar.  
We are collecting information on factors contributing  to tuberculosis infection among 
pregnant women atending ANC service in the hospital. We would very much appreciate  
your participation in this effort. Whatever information you provide will be kept strictly 
confidential. We will record your name on the questionnaire. However, your name will 
not be identified in any output of this study. Participation in this study  is voluntary and 
you can choose not to answer any individual question or all of the  questions. You may 
also stop the interview completely at any time without any consequences at all. 
However, we  hope that you will participate in this study since the reults will help to 
develop strategies for government in tuberculosis control effors. You have full right to 
withdraw from this study at any time without a need to mention the reason why you 
wanted to withdraw. We value your input to make this study a successful one.  
  You will not get or provided intensive or payments that you are participating in the study       
rather it is full of voluntary as I mentioned before. At this time, do you want to participate 
in the study? If you have questions about the research please contact:-  Adugna Berju 
who is principal investigator of this study in the University of Gondar, at 
+251(0)918212151 or Dr. Takele Tadesse at +251(0)918773317. At this time , do you 
want to ask me anything about the purpose or content of this interview? 
1. Yes       2. No  
If the response is “Yes”,  procide to the next page. 
If the response is “No”, thank the respondent and stop there. 
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 Part 1:- General information 
                           Socio demographic and economic condition  
 
No Question Response  Remark  
101 ID No 
 
 
      
 
 
102 Age/years 
 
 
  
 
 
103  Ethnicity  Amhara ………………1 
Oromo ………………..2 
Tigiry …………………3 
Others ………………..4 
 
104 Religion  Orthodox ……………..1 
Muslim …………….....2 
Catholic ……………...3 
Protestant ……………4 
 
105 Educational 
status 
 
 
No school ………………….....................1 
Read and write     ………. ……………...2 
Primary school   ………………………....3 
Secondary school……………………….4 
Above secondary school………………..5  
 
106 Marital 
status 
 
 
Single …………………..1 
Married ……………........2 
Divorced ………………..3 
Widowed ……………….4 
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No Question Response  Remark  
107 Occupational 
status 
Peasant   ………………………..1  
student ………………………......2  
Daily labor  ………………..........3 
Civil servant…………….……….4 
NGO……...………………………5 
Privet business …………………6 
House wife………………………7 
 
 
 
 
108 Residence  Urban ……………………….1 
Rural ………………………...2 
 
 
 
Part 2 - Current illness and Duration 
No Question Response  Remark 
201 Did you experience cough for two weeks or  
More? 
Yes ………………..1 
No ……………….. 2 
If no, 
203 
202 If you say” yes”for Q. No.201 how long have 
it been since your current symptom starts? 
In days  
  
 
 
203 Do you have of sputum? 
 
Yes………………...1 
No …………………2 
 
204 If yes for to203, for how long? In  days 
  
 
 
205 Do you have blood in sputum? Yes………………...1 
No …………………2 
 
206 If yes to205, for how long? In days 
  
 
 
207 Do you have fever? 
 
 
Yes ………………..1 
No …………………2 
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No Question Response  Remark 
208 Did you have night sweet? 
 
Yes …………...1 
No …………….2 
 
209 If yes to208, for how long? In days 
  
 
 
210 Do you have loss of appetite?   Yes……………..1 
No ……………...2 
 
211 If your answer is yes for Q No 208, for how 
many days? 
In days  
  
 
 
212 Did you have weight loss? Yes…………….1 
No ……………..2 
 
213 Do you have LN swelling? Yes ……………1 
No……………...2 
 
 
214 Did you have chest pain? Yes…………….1 
No ……………..2 
 
 
215 If yes to214, for how long? In days  
  
 
 
216 Did you have shortness of breath? Yes…………….1 
No ……………..2 
 
 
217 If “yes” to 216, for how long? In days  
  
 
 
218 Do you give sputum samples for Lab? 
 
Yes……………1 
No …………….2 
 
219 Reason for not providing sputum sample Not able to produce sputum……..1 
Not willing to produce sputum…….2 
Not present ………………………….3 
Other(specify)……………………….4 
 
 
 
 
 
 
 
 
220 Smear result for those who provide sputum Positive…………………….1  
Negative ……………………2 
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Part 3:-Environmental and Behavioral factors 
No  Question  Answer  Remark  
301 Number of people in house hold  
 
In No. 
  
 
 
302 Number of room 
 
In No. 
  
 
 
303 Person per room In No. 
  
 
 
304 Family history of TB None ……………….1 
One…………………2 
More than one……..3 
 
305 Wall construction material Wood with mud………1 
Cement/ blocks……....2 
Wood only…………….3 
 
 
306 Floor type Mud /soil……………..1 
Cement………………2 
Wood…………………3 
 
 
 
307 Window    
 
 
 
308 Do you have separate kitchen 
 
Yes……………1 
No ....................2 
 
 
309  Do you have animals  
 
Yes…………….1 
No ……………...2 
 
 
310 Do your animals share your house  Yes……………..1 
No………………2 
 
311 Type of house you are living in  Wood, mud and crop residence 
……………..1 
Wood, mud and stainless 
still……………………………...2  
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No  Question  Answer  Remark  
Stone/brocket, and SS……….3 
Others…………………………..4 
 
313 Main type of light source at home  Electric……………..............1 
Gas …………………………2 
Wood………………………..3 
Battery /hand ………………4 
Others ………………………5 
 
 
314 What is the main source of fuel for 
cooking at home? 
 
Wood…………………….1 
Plant residue …………...2 
Animal dung…………….3 
Electric …………………..4 
Charcoal ………………...5 
Gas ……………………….6 
Others……………………..7 
 
315 Do you drink alcohol Yes………………….1 
No…………………...2 
 
316 If your answer is “yes” for Q No 
315, for how long period of time? /if 
it is less than one year pleas 
register “00” 
 
Years 
  
 
 
317 History of smoking 
 
Yes I have smock……….1 
Husband…………………2 
Family member………….3 
Work place……………….4 
There is no any smoke around 
me…………………………5 
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Part 4 Other clinical diseases history 
No  Question  Answer  Remark  
401 Do you have a problem of diabetics?  Yes ………….1 
No …………...2 
 
402 What is your HIV status Positive………..1 
Negative……….2 
Un known……..3 
 
 
403 Height in cm 
 
   
 
 
404 Weight in kg    
 
 
405 MUAC cm   
 
 
 
 
Thank you very much for taking time and providing valuable information 
Interviewer Name__________________signature____________Data___________ 
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TB suspect and Laboratory Register for PTB cases 
Smear result  Sr. 
No.  
Individual ID Sputum specimen
1.positive 2.negative 
Date Remark  
SP1  SP1    
SP2  SP2    
1  
SP3  SP3    
SP1  SP1    
SP2  SP2    
2  
SP3  SP3    
SP1  SP1    
SP2  SP2    
3  
 
SP3  SP3    
SP1  SP1    
SP2  SP2    
4  
SP3  SP3    
SP1  SP1    
SP2  SP2    
5  
SP3  SP3    
SP1  SP1    
SP2  SP2    
6  
SP3  SP3    
SP1  SP1    
SP2  SP2    
7  
SP3  SP3    
SP1  SP1    8  
SP2  SP2    
  SP3 
 
 SP3    
Name of Lab. Technologist__________________ Signature ________ Date_________ 
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Smear results for further Laboratory confirmation (quality control) 
Sr. 
No 
Individual ID Smear result 
1.positive 
2.negative  
Remark  
SP1   
SP2   
1  
SP3   
SP1   
SP2   
2  
SP3   
SP1   
SP2   
3   
SP3   
SP1   
SP2   
4  
SP3   
SP1   5  
SP2   
SP3   
 
Reported by                   confirmed by (senior Lab.Tec) 
Name ______________ Name__________________ 
Signature ___________ Signature________________ 
Date ________________ Date ___________________ 
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AMHARIC VERSION QUESTIONNAIRE 
በጎንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ ኮሌጅ 
የማህበለሰብ  ጤና ሳይንስ የድህረ ምረቃ ትምህርት ክፍል መረጃ መስጫ ቅፅ 
ይህ መጠይቅ የወሊድ ክትትል የሚያደርጉ Eናቶች የ ቲ.ቢ ሁኔታቸዉንና ተጓዳኝ ሁኔታወችን 
ለማጥናት የተዘጋጀ የዳሰሳ መጠይቅ ነዉ፡፡  
 የስምምነት ቃል 
ጤና ይስጥልኝ፡፡ ስሜ___________________________________ነው:: 
በጎንደር ዩኒቨርሲቲ በመጡ የጥናት ቡድኖች Aባላት የመረጃ ሰብሳቢ ነኝ፡፡ በAካባቢው በነፍሰጡር 
Eናቶች የቲቢ በሽታ ሁኔታን ለመዳሰስ  ወሳኝ የሆኑ መነሻዎችን ለማጥናት መርጃ በመሰብሰብ ላይ 
Eንገኛለን፡፡  የሚሰጡት መረጃ በሙሉ በከፍተኛ ምስጢር የሚያዝ ነው፡፡ ስምዎን በመጠየቁ ላይ 
Eንመዘግባለን፡፡ ነገር ግን ስምዎ ከማንኛውም ከዚህ ጥናት ውጤት ጋር Eይያያዝም፡፡ በዚህ ጥናት 
ውስጥ የሚያደርጉት ተሳትፎ በፈቃደኝነት ላይ የተመሰረተ ስለሆነ ከጥያቄዎች Aንዱን ወይም ከዚያ 
በላይ ላለመመለስ መወሰን ይችላሉ፡፡  በፈለገዎ ጊዜ ቃለ-ምልልሱን በሙሉ ቢያቋርጡ Eንኳ 
የሚደርስብዎ ነገር Aይኖርም፡፡ ከዚህ ጥናት የሚገኘው ውጤት መንግስት የቲቢ በሽታን 
ለመቆጣጠር ለሚያደርገው ጥረት የሚረዳ ነው፡፡  በዚህ ጥናት ለመሳተፍ ፈቃደኛ ባይሆኑ የቲቪም 
ሆነ ሌላ በሽታ ህክምና ማግኘት የሢችሉ መሆንዎንና ምንም Aይነት ጥቅምም ሆነ Eርዳታ 
Eንደማይቀርብለዎ ላስታውቀዎ Eወዳለሁ፡፡  
ጥያቄውን ተቀብሎ  ለመመለስ ተስማምተዋል ____________ 
ጥያቄውን Aልተቀበለም ___________ 
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  ክፍል 1:  የመላሾች ዲሞግራፊያዊ፡ Iኮኖሚያዊ ና ማህበራዊ ሁኔታን በሚመለከት  
ተ.ቁ ጥያቄ መልስ ምርመራ  
101 የመለያ ቁጥር …………………………….  
101 Eድሜ /በዓመት/ ………………………………  
102 ብሔር Aማራ________________1 
Oሮሞ________________2 
ትግሬ________________3 
ሌላ_________________4  
 
103 ሃይማኖት Oርቶዶክስ ___________ 1 
Eስላም _____________ 2 
ኘሮቴስታንት __________ 3 
ካቶሊክ  _____________4 
 
104 የትምህርት ሁኔታ ያልተማር_____________1  
ማንበብና መፃፍ የሚች-----2 
1ኛ ደረጃ _____________3 
2ኛ ደረጃ _____________4 
ከ2ኛ ደረጃ በላይ _______5 
 
105 የጋብቻ ሁኔታ ያላገባ/ች ----------------------1 
ያገባ/ች ------------------------2 
የተፋታ/ች --------------------3 
የሞተበት/ባት ----------------4 
 
106 የሥራ ሁኔታ AርሶAደር --------------------1 
ተማሪ ………...…………….2 
የቀን ሰራተኛ…………………3 
 
የመንግስት ሰራተኛ……….....4 
NGO……………..................5 
የግል ስራ…………………….6 
የቤት Eመቤት………………..7 
 
 
107 መኖሪያ ከተማ ---------------- 1 
ገጠር -------------------2 
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 ክፍል 2  የወቅቱን ህመምና የቆበትን ጊዜ በሚመለከት   
ተ.ቁ ጥያቄ መልስ ምርመራ  
201 ሁለት ሳምንትና ከዚያ በላይ የቆየ ሳል 
Aለብዎት? 
Aወን --------------------------1 
የለም --------------------------2 
   መልሱ የለም 
ከሆነ፣ ወደ ጥ. 
ቁ 205  
202 ለጥያቄ ቁጥር 201 የሰጡት መልስ “Aዎ” 
ከሆነ ይህ ምልክት ከጀመረ ምን ያህል ጊዜ 
ሆነው?  
 
በቀናት     
  
  
 
203 Aክታ Aለብዎት?  Aወን --------------------------1 
የለም --------------------------2 
 
204 መልስዎ Aዎ ከሆነ፤ ለምን ያህል ጊዜ? በቀናት 
  
 
 
205 Aክታው ደም Aለበት? Aወን --------------------------1 
የለም --------------------------2 
 
206 መልስዎ Aዎ ከሆነ፤ ለምን ያህል ጊዜ? በቀናት 
  
 
 
207 ትኩሳት Aለብዎት? Aወን --------------------------1 
የለም --------------------------2 
 
208 የሌሊት ላበት Aለብዎት? Aወን --------------------------1 
የለም --------------------------2 
 
209 ለጥያቄ ቁጥር 208 የሰጡት መልስ “Aዎ” 
ከሆነ ለምን ያህል ጊዜ? 
በቀናት 
  
 
 
210 የምግብ ፍላጎት መጥፋት? Aወን --------------------------1 
የለም --------------------------2 
 
211 ለጥያቄ ቁጥር 210 የሰጡት መልስ “Aዎ” 
ከሆነ ለምን ያህል ጊዜ? 
በቀናት   
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ተ.ቁ ጥያቄ መልስ ምርመራ  
  
 
212 ክብደትዎ ቀንሷል? Aወን --------------------------1 
የለም --------------------------2 
 
213 የEጢ Eብጠት /የመገጣጠሚያ/ Aለዎት? Aወን --------------------------1 
የለም --------------------------2 
 
214 
 
የደረት ህመም Aለብዎት ? Aወን --------------------------1 
የለም --------------------------2 
 
215 መልስዎ Aዎ ከሆነ፤ ለምን ያህል ጊዜ? በቀናት  
  
 
 
216 የትንፋሽ ማጠር Aለብዎት? Aወን --------------------------1 
የለም --------------------------2 
 
217 ለጥያቄ ቁጥር 216 የሰጡት መልስ “Aዎ” 
ከሆነ ለምን ያህል ጊዜ? 
በቀናት 
  
 
 
218 ለጥያቄ ቁጥር 217 የሰጡት መልስ “Aዎ” 
ከሆነ የAክታ ናሙና ለምርመራ 
ይሰጣሉን? 
Aወን --------------------------1 
የለም --------------------------2 
 
219 ለጥያቄ ቁጥር 218 የሰጡት መልስ “Aዎ” 
ከሆነ Aክታ የተወሰደበት /ቀን /ወርና/ 
ዓመት 
 ወዲያዉኑ   
ቀን        ወር    ዓ/ም 
   
ጧት 
   
ወዲያዉኑ 
    
 
220 ለጥያቄ ቁጥር 219 የሰጡት መልስ የለም 
ከሆነ ናሙና ያልሰጡበት ምክንያት 
ምንድነው? 
Aክታ ለማውጣት መቸገር-----1 
Aክታ ለመስጠት ፍቃደኛ Aለመሆን------2 
Aልነበረም/ Aልነበረችም--------3 
ሌላ ካለ ይገለፅ -----------------4 
 
219 የAክታ ምርመራ ውጤት ፖዘቲቭ -------------------------1 
ኔጌቲቭ ------------------------..2 
 
ክፍል  3  Aካባቢያዊ Eና ባህሪያዊ ምክንያቶቸችን በተመለከተ  
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ተ.ቁ ጥያቄ መልስ ምርመራ 
301 የቤተሰብ ብዛት    
 
302 የክፍሎች ብዛት    
 
303 በAንድ ክፍል  የተጠቃሚ ብዛት   
304 የቤተሰብ  በቲቪ በሽታ የሳንባ 
ነቀርሳ ታሪክ 
ምንም…………………………..1 
Aንድ Aባል……………………..2 
ከAንድ በላይ…………………….3 
 
 
305 ግድግዳዎች  Eንጨት በጭቃ-----------1 
ሲሚንቶ -------------------2 
Eንጨት -------------------3 
 
306 ወለል ጭቃ -----------------------1 
ሲሚንቶ -------------------2 
Eንጨት -------------------3 
 
307 የመስኮት ብዛት   
 
 
308 የተለየ ወጥ ቤት Aለዎት? Aወ ……………………..…1 
የለም……………………….2 
 
309 Eንሰሳት ከሰዎች ጋር ይኖራሉ? Aዎ………………………....1 
የለም ……………………….2 
 
310 የመኖሪያ ቤትዎ ምን Aይነት 
ነው? 
Eንጨት ጭቃና ሳ…………………...1 
Eንጨት ጭቃና ቆርቆሮ…………….2 
ከድንጋይ /ብሎኬት ቆርቆሮ………….3 
ሌላ ከሆነ ይገለ..……………………..4 
 
 
311 ለቤት መብራት ለማግኘት በብዛት 
የምትጠቀሙበት  ምንድነው? 
ኮረንቲ --------------------1 
ፋኑስ ---------------------2 
ኩራዝ ---------------------4 
የEጅ ባትሪ --------------- 5 
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ተ.ቁ ጥያቄ መልስ ምርመራ 
የማገዶ Eንጨት ---------- -6 
ሌላ ከሆነ ይገለፅ -------  7 
313 መጠጥ ይጠጣሉ? Aወን ----------------------------1 
የለም ----------------------------2  
 
314 ለጥያቄ 316 የሰጡት መልስ 
“Aዎ” ከሆነ ለምን ያህል ጊዜ 
ሲጠጡ ነበር? /ከAንድ ዓመት 
በታች/ያነሰ ከሆነ “00” ይመዝግቡ 
 
ዓመታት 
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 ክፍል 4:ተጓዳኝ ህመሞችን በተመለከተ፡-         
ተ.ቁ ጥያቄ መልስ ምርመራ  
401 የስኳር በሽታ Aለብወ? Aወን --------------------------1 
የለም --------------------------2 
 
402 የኤች Aይቪ ሁኔታ 1.ፖዘቲቭ     
2. ኔጌቲቭ    
3. Aይታዎቅም 
 
403 ቁመት በሴ.ሜ    
404 ክብደት በኪ.ግ   
405 MUAC በሴ.ሜ   
 
 
የስራ ጊዜዎን ሰውተው ስለሰጡን Eጅግ ጠቃሚ መረጃ በጣም Aመሰግናለሁ:: 
 
የቃለ- ምልልስ Aቅራቢ  ፊርማ____________________ ቀን ______________ 
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Annex 1: information sheet and consent form  
 
• Title of the research project 
Prevalence  of smear positive tuberculosis and associated factors among pregnant 
women attending ANC in North Gondar Zone hospitals. Institution based cross sectional 
study.  
• Name of investigator:  Adugna Berju (DVM) 
• Name of the Advisors: 
1. Dr.Takele Tadesse (PHD, Associate proffesor) 
2. Dr Sileshi Nigatu (DVM, VPH) 
• Name of the organization : university of Gondar  College of medicine and health 
science, school of public health 
• Name of sponsor : university of Gondar   
Introduction  
This information sheet and consent form is prepared with the aim of explaining the 
research project that you are asked to join by the group of research team. The main aim 
of this research project is to determine the prevalence of smear positive tuberculosis 
and associated factors among pregnant women attending ANC in North Gondar Zone 
Hospitals.   
This research team includes one principal investigator, three nurses as data collector, 
three laboratory technician, three supervisors and two advisors from University of 
Gondar. 
Purpose: 
The purpose of this research study is there for to determine the prevalence of smear 
positive tuberculosis and associated factors among pregnant women attending ANC in 
North Gondar Zone Hospitals, North west Ethiopia. The information that you will provide 
us will help us to determine the prevalence, and identify main factors which contribute to 
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TB in pregnant women. The result of this study used to improve TB prevention and 
control program in pregnant women in the study area in particular and in Ethiopia in 
general through early detection of TB which decreases maternal and child mortality. 
Procedures 
If you agree to participate in this study, you kindly requested to give us the correct 
information about yourself add the study participant for this study are pregnant women 
attending ANC in all Hospitals of North Gondar Zone.  
Potential risks and discomfort of being in the study 
By participating in this research project, you may have some discomfort. There are no 
or minimal anticipated risk but taking time about 1 hour for interview. 
Benefits of being in the study 
There may not be direct benefits to you for giving us information for the study.  
Confidentiality and Privacy Protections: 
The records of this study will be stored securely and kept confidential. All publications 
will exclude any information that will make it possible to identify you as a subject.  
Person to contact  
If in case anyone wanted to know more information about the research and related 
issues, he/she could contact responsible bodies of the research through the following 
addresses.   
1. Adugna Berju (DVM): principal investigator 
Cell phone +251(0) 918212151 
E-mail: adushet@gmail.com 
2. Dr. Takele Tadesse, University of Gondar College of medicine and health Sci. 
 Cell phone:  +251(0)918773317 
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E-mail  
3.  Dr. Seleshe Nigatu, 
Cell phone…………………….. 
E-mail …………………………….. 
Name of study 
participant:_______________________Signature__________Date:___________ 
Name of 
witness____________________Signature:_____________Date_______________ 
Name of 
investigator/representative/:______________Signature__________Date_________ 
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በጎንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ ኮሌጅ 
የማህበረሰብ ጤና ሳይንስ የድህረ ምረቃ ትምህርት ክፍል 
የጥናቱ ማብራሪያ Eና የስምምነት ማረጋገጫ ፎርም 
 
ይህ የIንፎርሜሽን መስጫና የስምምነት ማረጋገጫ ፎርም የተዘጋጀዉ  የጥናቱ ተሳታፊዎች 
ስለሚካሄደዉ ጥናት ግንዛቤ ኑሮAቸዉ የበኩላቸዉን AስተዋፅO Eንዲያደርጉ ነዉ፡፡   
ጥናቱ የሚካሄደዉ በስሜን ምEራብ Iትዬጰያ ሰሜን ጎንደር ዞን በሚገኙ ሆስፒታሎች ሲሆን የጥናቱ 
ዋና Aላማ የEርግዝና ክትትል የሚያደርጉ ነፍሰጡር Eናቶች የ ቲ.ቢ ሁኔታ Eና AስተዋፀO 
የሚያደርጉ መንስኤዎችን ለመለየት ነዉ፡፡ 
 
የጥናቱ ቡድኖች የሚከተሉት ናቸዉ 
1.  ዶ/ር Aዱኛ በርጁ (DVM) 
2. ዶ/ር ታከለ ታደሰ (PHD,Associate professor) 
3. ዶ/ር ስለሺ ንጋቱ (DVM,VPH) 
 
የጥናቱ ዓላማ 
የዚህ ጥናት ዋና Aላማ በስሜን ምEራብ Iትዬጰያ በሰሜን ጎንደር ዞን በሚገኙ ሆስፒታሎች ላይ 
የEርግዝና ክትትል የሚያደርጉ ነፍሰጡር Eናቶች የ ቲ.ቢ Eና መንስኤዎችን መመርመር ነው፡፡
የሚሰጡን መረጃ ይህ ጥናት በሚካሄድበት Aካባቢ በተለይ በIትዬጰያ በAጠቃላይ Eናቶችን ከቲቢ 
በሽታ ለመከላከልና ለመቆጣጠር ለምናደርገው ዝግጅት ይረዳናል፡፡ ይህ ጥናት Eድሜዓቸው ከ18 
ዓመትና ከዚያ በላይ የሆኑ  ነፍሰጡር Eናቶች በዞኑ በሚገኙ ሆስፒታሎች በ 1271 Eናቶችን 
ያካትታል፡፡  
 
የጥናቱ Aካሄድ  
በዚህ ጥናት ውስጥ ለመሳተፍ የሚስማሙ ከሆነ የሚከተሉትን Eንዲፈፀሙ Eንጠይቃለን፡፡ 
 
• ከቲቢ በሽታ ጋር የሚዛመዱ ምልክቶች ስለመኖራቸው ቃለ-ምልልስ Eናደርግለዎታለን፡፡  
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• ስለህመሙ ምልክቶች ከምናደርገው ቃለ-መጠይቅ በምናገኘው መረጃ መሰረት ሁለት ጊዜ 
የAክታ ናሙና Eንዲሰጡ ይጠየቃሉ፡፡ Aንዱ ናሙና ቃለ-መጠይቁ Eንዳበቃ፣ ሁለተኛው 
ደግሞ በማግስቱ ጥዋት ይሰጣል፡፡ 
• ከጥናቱ ጋር ተያይዞ በሚሰጠው ህክምና ለምርመራ የሚፈለገውን የAክታና የደም ናሙና 
Eንዲሰጡ የሚጠይቁበት ሁኔታ ሊኖር ይችላል፡፡ 
• በAጠቃላይ ግምት ቃለ-ምልልሱ Aንድ ስዓት ይወስዳል፡፡  
 
  
በተሳትፎ ምክንያት የሚደርስ Aደጋ  
በዚህ ጥናት ይደረሳል ተብሎ የሚገመት Aደጋ የለም፡፡ 
 
በጥናቱ መሳተፍ የሚያስገኘው ጥቅም 
በዚህ ጥናት በመሳተፍዎ በቀጥታ የሚገኝ ምንም Aይነት ጥቅም የለም፡፡ 
 
የመረጃው ሚስጥራዊ Aያያዝ 
በዚህ ጥናት ውስጥ የሚመዘገብ መረጃ ሁሉ ደህንነቱ በተረጋገጠ ሁኔታ በምስጢር ይከማቻል፡፡ 
የሚታተሙ ፁሁፎች ሁሉ የEርስዎን ማንነት ይፋ የሚያደርጉ ነገሮችን Aያካትቱም፡፡  
 
መረጃን በተመለከተ 
ስለጥናቱ ጥያቄ ካለዎት Eባክዎ Aሁን ይጠይቁኝ፡፡ ወደፊትም ቢሆን ጥያቄ ሲኖርዎት፣ ተጨማሪ 
መረጃ ሲያስፈልግዎት፣ በቀጣይ ተሳትፎዎን ለማቋረጥ ሲፈልጉ ደግሞ ዝም ብለው ለEኔ ይንገሩኝ፡፡ 
ከዚህ ጥናት በማንኛውም ጊዜ ሊሰናበቱ ይችላሉ፡፡ 
 
በጥናቱ ለመሳተፍ ፈቃደኛ ነዎት?     1. Aዎ       2. Aይደለም 
 
የጥናቱ ተሳታፊ ስም____________________ፊርማ____________ 
መጠይቁ የተካሄደበት ቀን -------------------------------------------------------- 
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